Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Aromatic Hydrocarbon Receptor
100%
Benzo[a]anthracene
16%
BRCA1 Gene
41%
Breast Cancer
100%
Breast Cancer Cases
8%
Breast Cancer Cells
8%
Breast Cancer Treatment
8%
Breast Malignancy
8%
Breast Tumor
33%
Breast Tumorigenesis
100%
Constitutive Expression
100%
CpG Methylation
100%
Cyclin D1 (CCND1)
8%
Cyclin-dependent Kinase 4 (CDK4)
8%
CYP1B1
16%
Cytochrome P450 1A1 (CYP1A1)
8%
Dietary Factors
8%
Dimethyl
16%
Downstream Targets
8%
Environmental Exposure
8%
Environmental Factors
8%
Epidermal Growth Factor Receptor 2
8%
Estradiol
8%
Estrogen Receptor-α (ER-α)
8%
Genetic Modification
8%
Germline mutation
8%
Human Epidermal Growth Factor Receptor 2 (HER2)
16%
HyPer
8%
Hypermethylated
16%
Hypomethylating Agents
8%
Mammary Carcinogen
8%
Mammary Tumor
16%
MCF-7
8%
MCF-7 Cells
8%
Membrane Estrogen Receptor
8%
Predictive Marker
8%
Proliferation Marker
8%
Promoter Expression
8%
Promoter Methylation
8%
Receptor 1
100%
Receptor Agonist
8%
Receptor Antagonist
8%
Receptor Expression
16%
Receptor Modulators
8%
Sprague-Dawley Rats
8%
Triple Negative
8%
Tumor
8%
Tumor Development
8%
Tumor Samples
8%
α-naphthoflavone
25%
Medicine and Dentistry
Aromatic Hydrocarbon Receptor
100%
Benz[a]anthracene
18%
Biological Marker
100%
Breast Cancer
27%
Breast Tumor
36%
Cancer
9%
Cancer Cell
9%
Cancer Therapy
9%
Carcinogen
9%
Carcinogenesis
100%
Cyclin D1
9%
CYP1B1
9%
Cytochrome P450 1A1
9%
Diethylstilbestrol
9%
Environmental Exposure
9%
Epidermal Growth Factor Receptor 2
9%
Estrogen Receptor
9%
Gene Mutation
9%
Germline Mutation
9%
MCF-7
18%
Methylation
36%
Predictive Marker
9%
Promoter Region
100%
Receptor Antagonist
9%
Receptor Expression
18%
Somatics
9%
Triple Negative Breast Cancer
27%
Tumor
27%
Pharmacology, Toxicology and Pharmaceutical Science
Aromatic Hydrocarbon Receptor
100%
Benz(a)anthracene
18%
Biological Marker
100%
Breast Cancer
27%
Breast Tumor
36%
Carcinogen
9%
Carcinogenesis
100%
Cyclin D1
9%
CYP1B1
9%
Cytochrome P450 1A1
9%
Diethylstilbestrol
9%
Environmental Exposure
9%
Epidermal Growth Factor Receptor 2
9%
Estrogen Receptor
9%
Receptor Agonist
9%
Receptor Antagonist
9%
Sprague Dawley Rat
9%
Triple Negative Breast Cancer
27%
Immunology and Microbiology
Agonist
16%
Cancer Cell
16%
Cyclin D1
16%
Epidermal Growth Factor
16%
Gene Mutation
16%
Germline Mutation
16%
Methylation
66%
Promoter Region
100%
Sprague Dawley Rat
16%